ONCOSTING, LLC
Baltimore, United States · Founded 2021 · $2.6M raised
- Headquarters
- Baltimore, Maryland
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- oncosting.com
- Total Funding
- $2.6M
- Last Round
- $2.6M GrantSep 2021
- Rounds
- 1
About
OncoSTING is a biotechnology company developing recombinant BCG immunotherapies that overexpress STING agonists for the treatment of non-muscle-invasive bladder cancer and tuberculosis. Its lead candidates OS-101 and OS-151 are engineered to enhance anti-tumor and anti-TB immune responses via the innate immune STING-IRF3-NF-κB pathway. The company has received NIH and NSF SBIR/STTR funding totaling over $3.7M.
Summary
ONCOSTING, LLC is a Biotech company based in Baltimore, United States, founded in 2021. It has raised $2.6M in total across 1 round, most recently a $2.6M Grant round in Sep 2021. Investors include National Institute on Aging.
Funding History
Sep 2021
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oncosting-llc"><img src="https://indexed.vc/api/badge/company/oncosting-llc" alt="ONCOSTING, LLC on Indexed.vc" width="260" height="76" /></a>